New trial

[Beckey]

parkinsonsnewstoday.com/201...

[bassofspades]

Too bad it isnt a pde5 inhibitor!

[Beckey in reply to bassofspades]

What does that mean, bassofspades? (You've got to tell some people everything)

[Mike1942 in reply to Beckey]

I'll join in with it Becket if you are up for it

[Hidden]

If you can, join the trial. It may be of benefit, and it would be free. Go for it.

[Sleeplessparki]

Hi Becky, are you going to join the study? When is it taking time place?

[jrg54321]

Locations

United States, Georgia

Atlanta Center for Medical ResearchRecruiting

Atlanta, Georgia, United States, 30331

United States, North Carolina

Duke Early Phase Research UnitRecruiting

Durham, North Carolina, United States, 27708

[Sleeplessparki in reply to jrg54321]

Thanks jrg that was my next question

[park_bear in reply to jrg54321]

more info at this link: clinicaltrials.gov/ct2/show...

is a 1-week trial

[Beckey in reply to jrg54321]

Phooey!

[bassofspades]

Beckeu a pde 5 inhibitor is like viagra or cialis lol!

[Beckey in reply to bassofspades]

Oh! Ha ha ha!

[park_bear]

"Preclinical studies suggest that PDE1 inhibitors potentiate L-DOPA and other dopamine replacement therapies for motor symptom control at lower doses of dopamine replacement therapies while inhibiting the adverse dyskinesias induced by these treatments"

Preclinical is a low level of evidence, and company PRs may exaggerate, but OTOH if this pans out could be big deal.

Anyone who is able to sign up should consider, and keep us posted!